Vous êtes sur la page 1sur 2

Case Processing Summary

Cases

Valid Missing Total

N Percent N Percent N Percent

Kecacingan * HB 64 100,0% 0 0,0% 64 100,0%

Kecacingan * HB Crosstabulation

HB Total

<10mmHg >10mmHg

Count 14 48 62

Expected Count 14,5 47,5 62,0

Negatif % within Kecacingan 22,6% 77,4% 100,0%

% within HB 93,3% 98,0% 96,9%

% of Total 21,9% 75,0% 96,9%


Kecacingan
Count 1 1 2

Expected Count ,5 1,5 2,0

Positif % within Kecacingan 50,0% 50,0% 100,0%

% within HB 6,7% 2,0% 3,1%

% of Total 1,6% 1,6% 3,1%


Count 15 49 64

Expected Count 15,0 49,0 64,0

Total % within Kecacingan 23,4% 76,6% 100,0%

% within HB 100,0% 100,0% 100,0%

% of Total 23,4% 76,6% 100,0%

Chi-Square Tests

Value df Asymp. Sig. (2- Exact Sig. (2- Exact Sig. (1-
sided) sided) sided)

Pearson Chi-Square ,812a 1 ,368


Continuity Correctionb ,003 1 ,958
Likelihood Ratio ,689 1 ,407
Fisher's Exact Test ,417 ,417
Linear-by-Linear
,799 1 ,371
Association
N of Valid Cases 64

a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is ,47.
b. Computed only for a 2x2 table
Risk Estimate

Value 95% Confidence Interval

Lower Upper

Odds Ratio for Kecacingan


,292 ,017 4,967
(Negatif / Positif)
For cohort HB = <10mmHg ,452 ,105 1,946
For cohort HB = >10mmHg 1,548 ,385 6,232
N of Valid Cases 64

Vous aimerez peut-être aussi